A non-linear beta-binomial regression model for mapping EORTC QLQ- C30 to the EQ-5D-3L in lung cancer patients: a comparison with existing approaches

SOCCAR: A randomised phase II trial comparing sequential versus concurrent chemotherapy and radical hypofractionated radiotherapy in patients with inoperable stage III Non-Small Cell Lung Cancer and good performance status

(2014) J. Maguire et al.   EUROPEAN JOURNAL OF CANCER

Mapping to Obtain EQ-5D Utility Values for Use in NICE Health Technology Assessments

(2013) Louise Longworth et al.   VALUE IN HEALTH

Mapping for economic evaluation

(2012) L.-H. Chuang et al.   BRITISH MEDICAL BULLETIN

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

(2012) Siow Ming Lee et al.   LANCET ONCOLOGY

An assessment of the external validity of mapping QLQ-C30 to EQ-5D preferences

(2012) Ralph Crott et al.   QUALITY OF LIFE RESEARCH

Tails from the Peak District: Adjusted Limited Dependent Variable Mixture Models of EQ-5D Questionnaire Health State Utility Values

(2012) Mónica Hernández Alava et al.   VALUE IN HEALTH

Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysis

(2012) William Dunlop et al.   JOURNAL OF MEDICAL ECONOMICS

A Systematic Review of Economic Evaluations in Second and Later Lines of Therapy for the Treatment of Non-Small Cell Lung Cancer

(2012) Anne Jäkel et al.   Applied Health Economics and Health Policy

A general class of zero-or-one inflated beta regression models

(2011) Raydonal Ospina et al.   COMPUTATIONAL STATISTICS & DATA ANALYSIS

Probabilistic Mapping of Descriptive Health Status Responses Onto Health State Utilities Using Bayesian Networks

(2011) Quang A. Le et al.   MEDICAL CARE

Regression Estimators for Generic Health-Related Quality of Life and Quality-Adjusted Life Years

(2011) Anirban Basu et al.   MEDICAL DECISION MAKING

Sample Size Determination for Cost-Effectiveness Trials

(2011) Andrew R. Willan   PHARMACOECONOMICS

Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients

(2011) Eun-ju Kim et al.   QUALITY OF LIFE RESEARCH

Deriving a Preference-Based Measure for Cancer Using the EORTC QLQ-C30

(2011) Donna Rowen et al.   VALUE IN HEALTH

Mapping onto Eq-5 D for patients in poor health

(2010) Matthijs M Versteegh et al.   Health and Quality of Life Outcomes

Mapping the Cancer-Specific EORTC QLQ-C30 to the Preference-Based EQ-5D, SF-6D, and 15D Instruments

(2009) Nick Kontodimopoulos et al.   VALUE IN HEALTH

The Use of QALY Weights for QALY Calculations

(2008) Paul A Scuffham et al.   PHARMACOECONOMICS

Mapping the EORTC QLQ C-30 onto the EQ-5D Instrument: The Potential to Estimate QALYs without Generic Preference Data

(2008) Lynda McKenzie et al.   VALUE IN HEALTH